IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Virtus Advisers, LLC

Q1 2019 Holdings

Filed 2019-05-14 | 158 holdings | $6.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$273.0K33,7584.4%
Akebia Therapeutics Inc(AKBA)COM00972D105$274.0K33,5144.4%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$333.0K18,1205.4%
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$500.0K4,2508.1%
Biogen Inc(BIIB)COM09062X103$562.0K2,3769.1%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$736.0K8,28511.9%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$959.0K10,26215.5%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$981.0K14,54015.9%
PreviousPage 4 of 4